Drug Institute Tackles Neurology of Addiction

Tracing its origin back 60 years to the Research Division of the United States Narcotics Farm--a treatment facility for opiate addicts located in Lexington, Ky.--the National Institutes of Health's National Institute on Drug Abuse (NIDA) has grown into the world's largest drug addiction research facility. Sidebar: DISCUSSING THE SCIENCE BEHIND DRUG ADDICTION "This institute intramurally and extramurally provides 85 percent of the world support for research on drug abuse and addiction," remark

Written byKaren Young Kreeger
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Sidebar: DISCUSSING THE SCIENCE BEHIND DRUG ADDICTION

"This institute intramurally and extramurally provides 85 percent of the world support for research on drug abuse and addiction," remarks Alan I. Leshner, NIDA's director. "Our 1995 total budget for all of that is $437 million." While stressing that the figure is not large, he acknowledges that "that's not a bad budget by general NIH standards": Seven out of the 17 institutes have larger budgets. According to the 1995 budget report of the Office of National Drug Control Policy (ONDCP), $1.2 billion was spent by the united States government on preventing drug abuse.

George Uhl NIDA Researcher George Uhl and his colleagues look at drug addiction from the molecules up.

"First, NIDA's year 2000 goal is to have science replace ideology as the foundation of the nation's drug abuse prevention, treatment, and policy strategies." Second, because of this all-encompassing way of thinking about addiction, he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies